Cummins Inc
Change company Symbol lookup
Select an option...
CMI Cummins Inc
OTLY Oatly Group AB
SNLAF Sino Land Co Ltd
UE Urban Edge Properties
BRLIU Brilliant Acquisition Corp
CXDC China XD Plastics Company Ltd
BAC Bank of America Corp
PCRFY Panasonic Holdings Corp
CRTD Creatd Inc
MSM MSC Industrial Direct Co Inc
Go

Industrials : Machinery | Mid Cap Blend
Company profile

Cummins Inc. designs, manufactures, distributes and services diesel and natural gas, electric and hybrid powertrains and powertrain-related components. It is also a supplier of engine braking, cylinder deactivation, start and stop and thermal management technologies. Engine segment manufactures and markets a range of diesel and natural gas-powered engines under the Cummins brand name, as well as certain customer brand names, for the heavy and medium-duty truck. The Distribution segment consists of sales and support of a range of products and services. including power generation systems, high-horsepower engines, and heavy-duty and medium-duty engines. The Components segment supplies products, including aftertreatment systems, turbochargers, filtration products, electronics and fuel systems. The Power Systems segment consists of businesses, including power generation, industrial and generator technologies. The New Power segment focuses on hydrogen production and electric drive systems.

Closing Price
$250.90
Day's Change
-5.21 (-2.03%)
Bid
--
Ask
--
B/A Size
--
Day's High
257.69
Day's Low
249.25
Volume
(Heavy Day)
Volume:
1,267,730

10-day average volume:
863,741
1,267,730

AbbVie to Present at the Evercore ISI HealthCONx Conference

8:00 am ET November 23, 2022 (PR Newswire) Print

AbbVie (NYSE: ABBV) will participate in the 5th Annual Evercore ISI Virtual HealthCONx Conference on Tuesday, November 29, 2022. Rob Michael, vice chairman and president, Jeffrey R. Stewart, executive vice president, commercial operations, Scott Reents, senior vice president and chief financial officer, and Tom Hudson senior vice president, R&D and chief scientific officer, will present at 9:55 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, and women's health, in addition to products and services across our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us atwww.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTubeand LinkedIn.

https://c212.net/c/img/favicon.png?sn=CG43996&sd=2022-11-23

View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-evercore-isi-healthconx-conference-301685385.html

SOURCE AbbVie

https://rt.newswire.ca/rt.gif?NewsItemId=CG43996&Transmission_Id=202211230800PR_NEWS_USPR_____CG43996&DateId=20221123

comtex tracking

COMTEX_419541191/1005/2022-11-23T08:00:12

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.